Find the lowest price from 7,500+ FDA-registered pharmacies. Save up to 90%.
⭐ 4.7/5 Customer Rating
🏅 FDA-Registered Pharmacies
Prevents mast cells from degranulating — stopping the release of histamine, leukotrienes, and other inflammatory mediators before they trigger symptoms.
Blocks histamine H1 receptors directly at target tissues — a second line of action that manages symptoms even when some mediator release occurs.
Semaglutide combined with L-carnitine pairs GLP-1 receptor agonist therapy with an amino acid derivative essential for fatty acid transport into mitochondria. This combination is prescribed to enhance fat oxidation and support energy production during GLP-1-mediated weight loss.
Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Semaglutide activates GLP-1 receptors to suppress appetite, slow gastric emptying, and improve insulin sensitivity. L-carnitine is a naturally occurring amino acid derivative that shuttles long-chain fatty acids into the mitochondrial matrix for beta-oxidation — the process by which the body converts stored fat into usable energy. Together, they promote both reduced caloric intake and enhanced utilization of fat stores.
No commercially available product combines semaglutide with L-carnitine. Compounding allows prescribers to deliver both agents in a single injection, targeting both appetite reduction and fat metabolism optimization. Therapeutic doses of injectable L-carnitine far exceed what oral supplements can achieve due to poor oral bioavailability.
Compounded semaglutide with L-carnitine combines GLP-1 receptor agonist therapy with a key cofactor in mitochondrial fatty acid oxidation. While semaglutide reduces caloric intake through appetite suppression, L-carnitine supports the body's ability to efficiently convert mobilized fat stores into energy.
L-carnitine is synthesized endogenously from lysine and methionine but can become depleted during aggressive weight loss, caloric restriction, or in patients with carnitine deficiency. Injectable L-carnitine bypasses the limited oral bioavailability (~15–20%) and delivers therapeutic concentrations directly.
This combination is particularly popular among prescribers focused on body composition optimization — maximizing fat loss while supporting energy and reducing the fatigue commonly reported during GLP-1 therapy.
Semaglutide — GLP-1 Receptor Activation
Semaglutide binds to GLP-1 receptors on pancreatic beta cells, hypothalamic neurons, and gastric smooth muscle. This stimulates glucose-dependent insulin secretion, suppresses glucagon, delays gastric emptying, and reduces hunger by acting on central appetite centers.
L-Carnitine — Fatty Acid Transport and Oxidation
L-carnitine is required for the carnitine palmitoyltransferase (CPT) system, which transports long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Without adequate carnitine, fatty acids cannot enter the mitochondria efficiently, potentially reducing fat oxidation rates and contributing to fatigue. Injectable delivery achieves plasma concentrations 10–20x higher than oral supplementation.
Prescribed for patients with a documented clinical need for compounded semaglutide who also benefit from enhanced fat metabolism support:
BIND THIS TO: Mechanism Text CMS field (Rich Text). Then delete this paragraph and add a Rich Text element instead.
Athletic performance and recovery support, carnitine deficiency states, metabolic syndrome, statin-induced fatigue
⚠️ Dosing should be determined by your prescriber. The information below is general guidance only.
Typical semaglutide + L-carnitine dosing:
Weeks 1–4: Semaglutide 0.25mg + L-carnitine 200mg weekly
Weeks 5–8: Semaglutide 0.5mg + L-carnitine 200mg weekly
Weeks 9–12: Semaglutide 1.0mg + L-carnitine 200–500mg weekly
Weeks 13+: Semaglutide 1.7–2.4mg + L-carnitine 200–500mg weekly
L-carnitine dose may vary by pharmacy and prescriber protocol. Dosing is individualized.
Semaglutide titration follows the standard 4-week escalation schedule. L-carnitine does not typically cause side effects and does not require titration. Some prescribers increase L-carnitine dose as semaglutide dose increases to match the higher rate of fat mobilization at therapeutic doses.
Subcutaneous Injection — The standard form. Semaglutide and L-carnitine are combined in a single vial for weekly injection. This is the most common and clinically supported delivery method for this combination.
From semaglutide:
From L-carnitine:
GI side effects are primarily from semaglutide and typically improve with gradual titration.
Compounded semaglutide + L-carnitine is a 503A patient-specific preparation. Injectable L-carnitine (Carnitor) is FDA-approved for carnitine deficiency. The combination is not FDA-approved. Compounding remains legal for patients with documented clinical needs. Patients should verify pharmacy licensure and third-party testing.
L-carnitine is essential for transporting fatty acids into mitochondria where they are burned for energy. During GLP-1 therapy, the body mobilizes fat stores due to caloric restriction. L-carnitine ensures that mobilized fat can be efficiently oxidized rather than recirculated, supporting energy production and potentially enhancing fat loss outcomes.
Semaglutide and L-carnitine are each supported by substantial clinical evidence individually. L-carnitine supplementation has been shown to enhance fat oxidation during caloric restriction in multiple studies. The combination is based on complementary mechanisms of action, though large-scale trials of the specific combination are not yet published.
Typical pricing ranges from $199 to $479 per month depending on dose and pharmacy. Compounding Finder helps you compare options from multiple licensed pharmacies.
Yes, for therapeutic purposes. Oral L-carnitine has only 15–20% bioavailability. Injectable delivery achieves plasma concentrations 10–20 times higher, making it far more effective for clinical use. This is why the injectable combination is preferred over separate oral supplementation.
Yes. Compounded semaglutide + L-carnitine requires a valid prescription from a licensed healthcare provider.
1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
2. Pooyandjoo M, et al. The Effect of (L-)Carnitine on Weight Loss in Adults: A Systematic Review and Meta-Analysis. Obes Rev. 2016;17(10):970-976.
3. Fielding R, et al. L-Carnitine Supplementation in Recovery after Exercise. Nutrients. 2018;10(3):349.
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
Prevents mast cells from degranulating — stopping the release of histamine, leukotrienes, and other inflammatory mediators before they trigger symptoms.
